Skip to content

Evaluation of the efficacy and safety of abdominal respiratory training monitored by sEMG in the treatment of urinary retention after spinal cord injury: a randomized controlled clinical trial

Evaluation of the efficacy and safety of abdominal respiratory training monitored by sEMG in the treatment of urinary retention after spinal cord injury: a randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099288
Enrollment
Unknown
Registered
2025-03-20
Start date
2024-05-06
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention

Interventions

Test group:SEMG monitoring lower abdominal breathing training
Control group:Routine rehabilitation

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the "International Standards for the Neurological Classification of Spinal Cord Injuries" formulated by the American Spinal Cord Injury Association, and after the end of the spinal shock period, ASIA is graded as B, C, and D, and the clinical manifestations are urinary retention, residual urine > 100ml, and gender is not limited; 2. Age 16-80 years old; 3. The course of the disease is within 12 months; 4. Intermittent catheterization is feasible; 5. Pelvic floor muscle function test shows pelvic floor muscle hypotonia; 6. Have good communication skills, voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe urinary tract infection and hydronephrosis; 2. Those with other serious diseases; 3. Patients with respiratory failure or tracheostomy; 4. Patients with urinary retention not caused by spinal cord injury; 5. Dermato-to-electrode passers; 6. Patients with consciousness impairment and cognitive impairment; 7. Patients with poor treatment compliance and inability to follow doctor's instructions.

Design outcomes

Primary

MeasureTime frame
Bladder residual urine output at 3 weeks;

Secondary

MeasureTime frame
Glazer assessment value at 3 weeks;SF Quinaliveen Quality of Life Scale at 3 weeks;Urinary tract symptom score (LUTS) at 3 weeks;

Countries

China

Contacts

Public ContactHui Wei

Qilu Hospital of Shandong University

83926275@qq.com+86 18560083563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026